[Federal Register Volume 61, Number 43 (Monday, March 4, 1996)]
[Notices]
[Page 8303]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-4946]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 29, 1995, and published in the Federal 
Register on October 11, 1995, (60 FR 52923), Ciba-Geigy Corporation, 
Pharmaceuticals Division Regulatory Compliance, 556 Morris Avenue, 
Summit, New Jersey 07901, made application to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
methylphenidate (1724), a basic class of controlled substance listed in 
Schedule II.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Ciba-Geigy Corporation to 
manufacture the listed controlled substance is consistent with the 
public interest at this time. Therefore, pursuant to Section 303 of the 
Comprehensive Drug Abuse Prevention and Control Act of 1970 and Title 
21, Code of Federal Regulations, Section 1301.54(e), the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic class of controlled substance listed 
above is granted.

Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-4946 Filed 3-1-96; 8:45 am]
BILLING CODE 4410-09-M